Cacquevel M, Aeschbach L, Houacine J, Fraering PC.
Alzheimer's disease-linked mutations in presenilin-1 result in a drastic loss of activity in purified γ-secretase complexes.
PLoS One. 2012;7(4):e35133.
PubMed.
If it turns out that FAD mutations are generally loss of function, then the phenotype of haploinsufficiency would be the same as partial inhibition with γ-secretase inhibitors. Is this is why γ-secretase inhibitors failed in Phase 3? Maybe degrading APPβ CTF is a good thing?
Comments
University of California, Irvine
If it turns out that FAD mutations are generally loss of function, then the phenotype of haploinsufficiency would be the same as partial inhibition with γ-secretase inhibitors. Is this is why γ-secretase inhibitors failed in Phase 3? Maybe degrading APPβ CTF is a good thing?
Make a Comment
To make a comment you must login or register.